Santosh Y Dwivedi
About Santosh Y Dwivedi
Santosh Y Dwivedi has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Quality Kidney Care Private Limited and Diiacare Technologies Private Limited. Formerly with 2 companies, such as Ivy Prohealth Solutions Private Limited and Esponent Medtecno Solutions Llp. Engaged in General Business, Technology and more.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Quality Kidney Care Private Limited
U93090MH2018PTC308582
|
Director | 22 Dec 2018 | 2018 | Active |
Diiacare Technologies Private Limited
U32909DL2023PTC417863
|
Director | 31 Jul 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Ivy Prohealth Solutions Private Limited
U85300MH2020PTC350509
|
Director | 23 Nov 2020 | 2020 | Active |
|
Esponent Medtecno Solutions Llp
AAM-3540
|
Partner | 05 Mar 2025 | 2018 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Santosh Y Dwivedi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Santosh Y Dwivedi
Santosh Y Dwivedi has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Quality Kidney Care Private Limited and Diiacare Technologies Private Limited. Formerly with 2 companies, such as Ivy Prohealth Solutions Private Limited and Esponent Medtecno Solutions Llp. Engaged in General Business, Technology and more.
Santosh Y Dwivedi is associated with 2 companies as Director.
Santosh Y Dwivedi has expertise in General Business, Technology and other sectors.
Santosh Y Dwivedi has 7 years in corporate governance.